Find News

Filter articles

Applied Filters

Showing 31 to 40 of 706 results

LSPN 19: Humira litigation may prompt more antitrust scrutiny


The six antitrust class-action lawsuits that have been brought against AbbVie could result in more scrutiny of settlement agreements between the innovator and the biosimilar manufacturer, with potential antitrust complications.

LSPN 19: Courts need to revisit patentability of diagnostic tests


US courts need to revisit the patentability of diagnostic tests under section 101, according to Memorial Sloan Kettering Cancer Center’s chief IP counsel.

LSPN 19: Two bites at the apple here to stay, says Alkermes director


Petitioners will continue to be able to launch litigation simultaneously before both the district court and the Patent Trial and Appeal Board, effectively having two bites at the apple, according to John Kirkland, director of IP at biopharmaceutical company Alkermes.

Eli Lilly enters $35m immunology R&D deal


Eli Lilly has entered into a $35m global licensing and research agreement with biotech company Avidity Biosciences.

Hologics and Grifols agree $14m Enzo settlement


Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and Grifols, ending a patent dispute between the parties.

Fresenius files IPR against Amgen


Fresenius Kabi has submitted a petition for inter partes review of US patent number 9,856,287, a patent owned by Amgen.

Amgen appeals against PTAB Sanofi decision


Amgen subsidiary Immunex has appealed against a Patent Trial and Appeal Board decision which invalidated a patent claiming antibodies that target human interleukin-4 receptors.

China, Canada and US labs collaborate over neurological disorder therapies

Canada, China, US10-04-2019

Chinese companies have entered into a research agreement with scientists in the US and Canada to develop a therapy for neurological disorders by using the natural power of the immune system.

Duane Morris hires Winston & Strawn lawyer

Taiwan, US10-04-2019

Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.

Athena asks for rehearing on invalidated neurological disorder patent


Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.

Showing 31 to 40 of 706 results